Skip to content

Breast Cancer Health Center

Font Size
A
A
A

Types of Breast Cancer: ER Positive, HER2 Positive, and Triple Negative

One major way of defining your type of breast cancer is whether or not it is:

  • Endocrine receptor (estrogen or progesterone receptor) positive
  • HER2 positive
  • Triple negative, not positive to receptors for estrogen, progesterone, or HER2
  • Triple positive, positive for estrogen receptors, progesterone receptors and HER2

These classifications provide doctors with valuable information about how the tumor acts and what kind of treatments may work best.

Recommended Related to Breast Cancer

Soy and Breast Cancer: What's the Link?

To be safe, Jennifer Mukai all but eliminated soy from her diet after being told she had breast cancer in May 2009. Being of Japanese descent and also health conscious, the Seattle interior designer says she was eating a lot of soy in various forms before her diagnosis. “I drank about three-quarters of a cup of soy milk in my coffee twice a day and ate tofu and edamame [soy beans] pretty regularly,” the 44-year-old tells WebMD. “I was also probably getting quite a bit of soy in the meat-substitute...

Read the Soy and Breast Cancer: What's the Link? article > >

In general, surgical and radiation treatments are similar for these different types of breast cancer. But drug treatments -- such as chemotherapy, endocrine therapies, and other medications -- are usually different. These treatments are targeted to the specific type of cancer.

Hormone Receptor-Positive Breast Cancer

About 75% of all breast cancers are “ER positive.” They grow in response to the hormone estrogen. About 65% of these are also “PR positive.” They grow in response to another hormone, progesterone.

If your breast cancer’s cells have a significant number of receptors for either estrogen or progesterone, your cancer is considered hormone-receptor positive and likely to respond to endocrine therapies.

Breast cancer tumors that are ER/PR-positive are 60% likely to respond to endocrine therapy. Tumors that are ER/PR negative are only 5% to 10% likely to respond to endocrine therapy.

Endocrine therapies for breast cancer are treatments usually taken after surgery, chemotherapy, and/or radiation are finished. They are designed to help prevent recurrence of the disease by blocking the effects of estrogen. They do this in one of several ways.

  • The drug tamoxifen, taken by some women for up to 10 years after initial treatment for breast cancer, helps prevent recurrence by blocking the estrogen receptors on breast cancer cells and preventing estrogen from binding to them.
  • A class of drugs called aromatase inhibitors actually stops estrogen production in post-menopausal women. These drugs cannot be taken by women who have not yet gone through menopause.

 

HER2-Positive Breast Cancer

In about 20% to 25% of breast cancers, the cancer cells make too much of a protein known as HER2. These breast cancers tend to be much more aggressive and fast-growing.

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
 
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW